Jul 19,2021 Cell analysis instruments provider Cytek BioSciences sets terms for $248 million IPO read more >>
Jun 16,2021 KBP Biosciences Announces A Greater Than 10 mm Hg Systolic Blood Pressure Reduction in The BLOCK-CKD Phase 2b Study of KBP-5074 in Advanced Chronic Kidney Disease Patients with Uncontrolled Hypertension as Published in Hypertension read more >>
May 21,2021 Cardea Bio Partners with Scentian Bio to Power Insect Odorant Receptor-Enabled Flavor Profiling Product read more >>
May 18,2021 MD Anderson and Refuge Biotechnologies Collaborate to Advance Next-Generation Cell Therapies for Treatment of Solid Tumors read more >>